Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 16, 2021

Total Value: $319M (100.0% shares, 0.0% debt)

Holdings (13)

ENTA ENANTA PHARMACEUTICALS INC 16.7%

Value $53.22M Shares 936,777 Est. Cost $44.67 Unrealized +10.7%

ALKS ALKERMES PLC 13.9%

Value $44.47M Shares 1,441,967 Est. Cost $18.73 Unrealized +50.8%

REGN REGENERON PHARMACEUTICALS 13.9%

Value $44.27M Shares 73,143 Est. Cost $342.96 Unrealized +80.0%

UTHR UNITED THERAPEUTICS CORP 12.0%

Value $38.26M Shares 207,287 Est. Cost $121.76 Unrealized +61.8%

— TARO PHARMACEUTICAL INDUS 10.9%

Value $34.72M Shares 545,583 Est. Cost $78.11 Unrealized —

MCK MCKESSON CORP 10.3%

Value $32.82M Shares 164,591 Est. Cost $138.18 Unrealized +41.2%

BIIB BIOGEN INC 9.2%

Value $29.2M Shares 103,202 Est. Cost $311.97 Unrealized +5.1%

EXEL EXELIXIS INC 6.6%

Value $21.14M Shares 1,000,000 Est. Cost $18.57 Unrealized 0.0%

— SURGALIGN HOLDINGS INC 2.2%

Value $6.903M Shares 6,332,945 Est. Cost $1.82 Unrealized —

EGRX EAGLE PHARMACEUTICALS INC 1.9%

Value $6.012M Shares 107,773 Est. Cost $43.99 Unrealized +11.9%

— INVACARE CORP 1.3%

Value $4.242M Shares 891,259 Est. Cost $11.95 Unrealized —

TVTX TRAVERE THERAPEUTICS INC 1.0%

Value $3.327M Shares 137,203 Est. Cost $19.72 Unrealized -6.9%

— NEXTCURE INC 0.1%

Value $208K Shares 30,927 Est. Cost $9.95 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ENTA	ENANTA PHARMACEUTICALS INC	936,777	$53.22M	16.7%	$44.67	+10.7%	COM	29251M106
ALKS	ALKERMES PLC	1,441,967	$44.47M	13.9%	$18.73	+50.8%	COM	G01767105
REGN	REGENERON PHARMACEUTICALS	73,143	$44.27M	13.9%	$342.96	+80.0%	COM	75886F107
UTHR	UNITED THERAPEUTICS CORP	207,287	$38.26M	12.0%	$121.76	+61.8%	COM	91307C102
—	TARO PHARMACEUTICAL INDUS	545,583	$34.72M	10.9%	$78.11	—	COM	M8737E108
MCK	MCKESSON CORP	164,591	$32.82M	10.3%	$138.18	+41.2%	COM	58155Q103
BIIB	BIOGEN INC	103,202	$29.2M	9.2%	$311.97	+5.1%	COM	09062X103
EXEL	EXELIXIS INC	1,000,000	$21.14M	6.6%	$18.57	0.0%	COM	30161Q104
—	SURGALIGN HOLDINGS INC	6,332,945	$6.903M	2.2%	$1.82	—	COM	86882C105
EGRX	EAGLE PHARMACEUTICALS INC	107,773	$6.012M	1.9%	$43.99	+11.9%	COM	269796108
—	INVACARE CORP	891,259	$4.242M	1.3%	$11.95	—	COM	461203101
TVTX	TRAVERE THERAPEUTICS INC	137,203	$3.327M	1.0%	$19.72	-6.9%	COM	89422G107
—	NEXTCURE INC	30,927	$208K	0.1%	$9.95	—	COM	65343E108